重组人组织型纤溶酶原激活剂溶栓脑梗死患者卒中评分与血压测量结果分析

Analysis of the Apoplexy Score and Blood Pressure of the Cerebral Infarction Patients with Recombinant Human Tissue Fibrinolytic Enzyme Original Activators Thrombolysis

目的对脑梗死患者施行静脉溶栓治疗前后的相关状况和指标进行评价分析。方法 2003年1月2010年11月对神经内科收治的29例脑梗死患者予以静脉溶栓治疗及护理,并就治疗前后各相关时间点血压监测及美国国立卫生研究院卒中量表(National Institute of Health stroke scale,NIHSS)评分情况进行分析。结果溶栓前后血压对比显示:溶栓后2h收缩压相对于溶栓前和溶栓后24h升高(P<0.05);溶栓前后NIHSS评分差异有统计学意义(P<0.05)。结论溶栓后患者收缩压出现升高,护理上应该加强血压监控,为临床治疗提供支持。

Objective To investigate the correlated condition and clinical index changes before and after the intravenous thrombolysis of the cerebral infarction patients. Methods The blood pressure and the National Institutes of Health stroke scale （NIHSS） score of 29 cerebral infarction patients with the intravenous thrombolysis treatment between January 2003 and November 2010 were measured and analyzed. Results Two hours after the thrombolysis, the systolic blood pressure significantly increased compared with those before the intravenous thrombolysis and 24 hours after intravenous thrombolysis （P〈O. 05）. NIHSS score was significantly decreased after the thrombolysis （P〈0. 05）. Conclusions Systolic blood pressure significantly increases after the intravenous thrombolysis. Intensive blood pressure monitoring and controlling may be beneficial to the treatment and prognosis.